GabrielaSorianoHobbsMD

PubMed

• 1 citations
  Splenic irradiation for myelofibrosis prior to hematopoietic cell transplantation: A global collaborative analysis.
  Nico Gagelmann, Gabriela S Hobbs, Edoardo Campodonico, Grzegorz Helbig, Polona Novak, Thomas Schroeder, Artur Schneider, Christina Rautenberg, Hans Christian Reinhardt...> ;American Journal of Hematology. 2024 May 1
• Interferons in the treatment of myeloproliferative neoplasms.
  Pankit Vachhani, John Mascarenhas, Prithviraj Bose, Gabriela Hobbs, Abdulraheem Yacoub, Jeanne M Palmer, Aaron T Gerds, Lucia Masarova, Andrew T Kuykendall, Raajit K R...> ;Therapeutic Advances in Hematology. 2024 Jan 1
• In-Hospital and readmission outcomes of patients with myeloproliferative neoplasms and atrial fibrillation: insights from the National Readmissions Database.
  Orly Leiva, Joan How, Jeremy Grevet, Andrew Brunner, Gabriela Hobbs> ;Journal of Thrombosis and Thrombolysis. 2024 Feb 1
• 5 citations
  Outcomes of Patients With Myeloproliferative Neoplasms Admitted With Myocardial Infarction: Insights From National Inpatient Sample.
  Orly Leiva, Yuhe Xia, Emaad Siddiqui, Gabriela Hobbs, Sripal Bangalore> ;JACC. Cardiooncology. 2023 Aug 1
• Consensus recommendations on peripheral blood smear review: defining curricular standards and fellow competency.
  Matthew L Chase, Reed Drews, Marc S Zumberg, Leslie R Ellis, Erin G Reid, Aaron T Gerds, Alfred I Lee, Gabriela S Hobbs, Jonathan Berry, Jason A Freed> ;Blood Advances. 2023 Jul 11
• Pulmonary Hypertension in Myeloproliferative Neoplasms: New Insights and Unexplored Horizons.
  Orly Leiva, Brenda D Garcia, Gabriela Hobbs> ;American Journal of Respiratory and Critical Care Medicine. 2023 Sep 1
• 2 citations
  Risk Factors for Death or Cardiovascular Events after Acute Coronary Syndrome in Patients with Myeloproliferative Neoplasms.
  Orly Leiva, Andrew Jenkins, Rachel P Rosovsky, Rebecca K Leaf, Katayoon Goodarzi, Gabriela Hobbs> ;Hematology Reports. 2023 Jun 7
• Anxiety exacerbation in a patient with chronic myeloid leukemia receiving dasatinib and venlafaxine.
  Christopher Bell, Jessie Signorelli, Gabriela Hobbs> ;Journal of Oncology Pharmacy Practice. 2023 Oct 1
• 4 citations
  Psychological mobile app for patients with acute myeloid leukemia: A pilot randomized clinical trial.
  El-Jawahri, A., Luskin, M., Greer, J., Traeger, L., Lavoie, M., Vaughn, D., Andrews, S., Yang, D., Boateng, K., Newcomb, R., Ufere, N., Fathi, A., Hobbs, G., Brunner, ...> ;Cancer. 2023 Apr 1
• Author's reply.
  Orly Leiva, Gabriela Hobbs> ;Journal of Cardiology. 2023 Jun 1
• 4 citations
  Splenic irradiation prior to allogeneic hematopoietic cell transplantation for patients with myelofibrosis.
  John R Bales, Haesook T Kim, Roxana Portillo, Chirayu Patel, Steven McAfee, Bimalangshu Dey, Thomas Spitzer, Yi-Bin Chen, Areej El-Jawahri, Zachariah DeFilipp, Gabriel...> ;Bone Marrow Transplantation. 2023 Apr 1
• 9 citations
  Predictors of increased risk of adverse cardiovascular outcomes among patients with myeloproliferative neoplasms and atrial fibrillation.
  Orly Leiva, Andrew Jenkins, Rachel P Rosovsky, Rebecca Karp Leaf, Katayoon Goodarzi, Gabriela Hobbs> ;Journal of Cardiology. 2023 Mar 1
• 3 citations
  Pulmonary hypertension is associated with poor cardiovascular and hematologic outcomes in patients with myeloproliferative neoplasms and cardiovascular disease.
  Orly Leiva, Siyang Ren, Donna Neuberg, Ankeet Bhatt, Andrew Jenkins, Rachel Rosovsky, Rebecca Karp Leaf, Katayoon Goodarzi, Gabriela Hobbs> ;International Journal of Hematology. 2023 Jan 1
• 4 citations
  MPN-375 BET Inhibitor Pelabresib (CPI-0610) Combined With Ruxolitinib in Patients With Myelofibrosis - JAK Inhibitor-Naïe or With Suboptimal Response to Ruxolitinib - ...
  John Mascarenhas, Marina Kremyanskaya, Andrea Patriarca, Claire Harrison, Prithviraj Bose, Raajit K Rampal, Francesca Palandri, Timothy Devos, Francesco Passamonti, Ga...> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Oct 1
• 1 citations
  Interferons as the First Choice of Cytoreduction in Essential Thrombocythemia and Polycythemia Vera.
  Joan How, Gabriela Hobbs> ;Journal of the National Comprehensive Cancer Network. 2022 Sep 1
• 4 citations
  Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network.
  Dora Dias-Santagata, Rebecca S Heist, Adam Z Bard, Annacarolina F L da Silva, Ibiayi Dagogo-Jack, Valentina Nardi, Lauren L Ritterhouse, Laura M Spring, Nicholas Jesso...> ;The Oncologist. 2022 Nov 3
• 2 citations
  Patients with myeloproliferative neoplasms and COVID-19 have increased rates of arterial thrombosis.
  Orly Leiva, Umberto Campia, Julia Snyder, Briana M Barns, Samantha Rizzo, Candrika D Khairani, Andrew Brunner, Hanny Al-Samkari, Rebecca Karp Leaf, Rachel Rosovsky, Ka...> ;Research and Practice in Thrombosis and Haemostasis. 2022 Jul 1
• 7 citations
  Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine.
  Park, J., Mathieu Gigoux, Morten O Holmström, Roberta Zappasodi, Joseph J Park, Stephane Pourpe, Cansu Cimen Bozkus, Levi M B Mangarin, David Redmond, Svena Verma, Sar...> ;Science Translational Medicine. 2022 Jun 15
• 19 citations
  Cardiovascular Disease in Myeloproliferative Neoplasms:State-of-the-Art Review.
  Orly Leiva, Gabriela Hobbs, Katya Ravid, Peter Libby> ;JACC. Cardiooncology. 2022 Jun 1
• 4 citations
  Ixazomib in addition to chemotherapy for the treatment of acute lymphoblastic leukemia in older adults.
  Philip Amrein, Karen Ballen, Kristen Stevenson, Andrew Brunner, Gabriela Hobbs, Hanno Hock, Steven McAfee, Jenna Moran, Meghan Bergeron, Julia Foster, Christina Bertol...> ;Leukemia & Lymphoma. 2022 Jun 1
• Incidence of bleeding events in patients on concomitant tyrosine kinase inhibitors and selective serotonin reuptake inhibitors.
  Vinayak Venkataraman, John R Bales, Jessie Signorelli, Gabriela S Hobbs> ;Journal of Oncology Pharmacy Practice. 2023 Jul 1
• A nonrandomized phase I and biomarker trial of regorafenib in advanced myeloid malignancies.
  How, J., Ren, S., Lombardi-Story, J., Bergeron, M., Foster, J., Amrein, P., Brunner, A., Fathi, A., Hock, H., Khachatryan, A., Kikuchi, H., Ng, M., Moran, J., Narayan,...> ;Ejhaem. 2022 May 1
• 3 citations
  Antibody and T-cell responses to SARS-CoV-2 vaccination in myeloproliferative neoplasm patients.
  Joan How, Kathleen M E Gallagher, Yiwen Liu, Katelin Katsis, Eva L Elder, Rebecca C Larson, Mark B Leick, Donna Neuberg, Marcela V Maus, Gabriela S Hobbs> ;Leukemia. 2022 Apr 1
• 1 citations
  Chemotherapy Resistance in B-ALL with Cryptic NUP214-ABL1 Is Amenable to Kinase Inhibition and Immunotherapy.
  Valentina Nardi, Steven L McAfee, Paola Dal Cin, Harrison K Tsai, Philip C Amrein, Gabriela S Hobbs, Andrew M Brunner, Julia Foster, Amir T Fathi, Hanno Hock, Narayan, R.> ;The Oncologist. 2022 Mar 4
• 3 citations
  Transcriptional differences between JAK2-V617F and wild-type bone marrow cells in patients with myeloproliferative neoplasms.
  Debra Van Egeren, Baransel Kamaz, Shichen Liu, Maximilian Nguyen, Christopher R Reilly, Maria Kalyva, Daniel J DeAngelo, Ilene Galinsky, Martha Wadleigh, Eric S Winer,...> ;Experimental Hematology. 2022 Mar 1
• Join now to see all

Journal Articles

• Effectiveness of Integrated Palliative and Oncology Care for Patients with Acute Myeloid Leukemia  
  Areej El-Jawahri, Thomas W Leblanc, Selina M Luger, Bhavana Bhatnagar, Alison R Walker, Amir T Fathi, Andrew M Brunner, Gabriela S Hobbs, Jennifer S Temel, JAMA Oncology

Abstracts/Posters

• Pregnancy Outcomes, Risk Factors, and Gestational Cell Count Trends in Pregnant Women with Essential Thrombocythemia and Polycythemia Vera
  Gabriela S. Hobbs, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• Phase I Study of the Antibody-Drug Conjugate Brentuximab Vedotin Combined with Re-Induction Chemotherapy in Patients with CD30-Expressing Relapsed/Refractory Acute Mye... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Quality of Life and Psychological Distress in Patients with Acute Myeloid Leukemia (AML) 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018